CAP1 and cancer: Results showed that CAP1 protein levels were significantly upregulated in the serum of NSCLC patients compared with that of normal people (p < 0.0001, Normal 812.8 ± 44.95, N = 62, Cancer 1624 ± 66.47, N = 78) (Fig. 4a).